Exploration of the 5-bromopyrimidin-4(3H)-ones as potent inhibitors of PDE5

被引：10

作者：

Gong, Xudong ^{[1
]}

Wang, Guan ^{[2
]}

Ren, Jing ^{[2
]}

Liu, Zheng ^{[3
]}

Wang, Zhen ^{[2
]}

Chen, Tiantian ^{[2
]}

Yang, Xiaojun ^{[3
]}

Jiang, Xiangrui ^{[2
]}

Shen, Jingshan ^{[2
]}

Jiang, Hualiang ^{[2
]}

Aisa, Haji Akber ^{[1
]}

Xu, Yechun ^{[2
]}

Li, Jianfeng ^{[2
]}

机构：

[1] Chinese Acad Sci, Xinjiang Tech Inst Phys & Chem, Key Lab Xinjiang Indigenous Med Plants Resource U, Urumiqi 830011, Peoples R China

[2] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China

[3] Vitargeta Therapeut Inc, Plainsboro, NJ 08536 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2013年 / 23卷 / 17期

基金：

国家高技术研究发展计划(863计划); 中国国家自然科学基金;

关键词：

PDE5; inhibitors; 5-Bromopyrimidin-4(3H)-ones; DRUG DEVELOPMENT; PHOSPHODIESTERASE-5; DESIGN;

D O I：

10.1016/j.bmcl.2013.06.062

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The substituents both at the 6-position of the 5-bromopyrimidinone ring and at the 5'-position of the phenyl ring of 5-bromopyrimidin-4(3H)-ones were explored. 5-Bromo-6-isopropyl-2-(2-propoxyphenyl)pyrimidin-4(3H)-one was identified as a new scaffold for potent PDE5 inhibitors. The crystal structures of PDE5/2e and PDE5/10a complexes provided a structural basis for the inhibition of 5-bromopyrimidinones to PDE5. In addition, it was also found that there is a great tolerance for the substitution at the 5'-position of the phenyl ring of 5-bormopyrimidinones and the resulted compound 13a has the highest inhibition activity to PDE5 (IC50, 1.7 nM). (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：4944 / 4947

页数：4

共 17 条

[1] SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF 2-METHOXYPHENYL-SUBSTITUTED 9-DIALKYLAMINOETHYLIMIDAZO[1,2-a]BENZIMIDAZOLES
Anisimova, V. A.
Spasov, A. A.
Kosolapov, V. A.
Kucheryavenko, A. F.
Ostrovskii, O. V.
Larionov, N. P.
Libinzon, R. E.
[J]. PHARMACEUTICAL CHEMISTRY JOURNAL, 2005, 39 (09) : 476 - 483
[2] Structural basis for the activity of drugs that inhibit phosphodiesterases
Card, GL
England, BP
Suzuki, Y
Fong, D
Powell, B
Lee, B
Luu, C
Tabrizizad, M
Gillette, S
Ibrahim, PN
Artis, DR
Bollag, G
Milburn, MV
Kim, SH
Schlessinger, J
Zhang, KYJ
[J]. STRUCTURE, 2004, 12 (12) : 2233 - 2247
[3] Synthesis and cyclic GMP phosphodiesterase inhibitory activity of a series of 6-phenylpyrazolo [3,4-d]pyrimidones
Dumaitre, B
Dodic, N
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (08) : 1635 - 1644
[4] Phosphodiesterase: overview of protein structures, potential therapeutic applications and recent progress in drug development
Jeon, YH
Heo, YS
Kim, CM
Hyun, YL
Lee, TG
Ro, S
Cho, JM
[J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2005, 62 (11) : 1198 - 1220
[5] ANTIALLERGY AGENTS .1. 1,6-DIHYDRO-6-OXO-2-PHENYLPYRIMIDINE-5-CARBOXYLIC ACIDS AND ESTERS
JUBY, PF
HUDYMA, TW
BROWN, M
ESSERY, JM
PARTYKA, RA
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1979, 22 (03) : 263 - 269
[6] Mans D. J., 2012, J PHARM BIOMED ANA C, V75C, P153
[7] Ionic liquid-promoted, highly regioselective heck arylation of electron-rich olefins by aryl halides
Mo, J
Xu, LJ
Xiao, JL
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (02) : 751 - 760
[8] THE REACTION OF D-GLUCOSE WITH SUBSTITUTED ANILINES - INVESTIGATION BY C-13 NMR-SPECTROSCOPY
NELSON, DJ
LAVIN, MJ
[J]. JOURNAL OF CARBOHYDRATE CHEMISTRY, 1985, 4 (01) : 91 - 97
[9] The discovery of UK-369003, a novel PDE5 inhibitor with the potential for oral bioavailability and dose-proportional pharmacokinetics
Rawson, David J.
Ballard, Stephen
Barber, Christopher
Barker, Laura
Beaumont, Kevin
Bunnage, Mark
Cole, Susan
Corless, Martin
Denton, Stephen
Ellis, David
Floc'h, Marion
Foster, Laura
Gosset, James
Holmwood, Frances
Lane, Charlotte
Leahy, David
Mathias, John
Maw, Graham
Million, William
Poinsard, Cedric
Price, Jenny
Russel, Rachel
Street, Stephen
Watson, Lesa
[J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (01) : 498 - 509
[10] Phosphodiesterase 5 inhibitors: Current status and potential applications
Rotella, DP
[J]. NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) : 674 - 682

← 1 2 →